Absorption |
Blood-Brain Barrier | BBB+ | 0.9843 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7316 |
P-glycoprotein Substrate | Non-substrate | 0.6957 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9307 |
Non-inhibitor | 0.9721 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7734 |
Distribution |
Subcellular localization | Lysosome | 0.6679 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7755 |
CYP450 2D6 Substrate | Non-substrate | 0.8226 |
CYP450 3A4 Substrate | Non-substrate | 0.7131 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8974 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6730 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.7249 |
CYP450 2C19 Inhibitor | Inhibitor | 0.8342 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7023 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9514 |
Non-inhibitor | 0.8562 |
AMES Toxicity | AMES toxic | 0.9108 |
Carcinogens | Non-carcinogens | 0.9288 |
Fish Toxicity | High FHMT | 0.5766 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8835 |
Honey Bee Toxicity | High HBT | 0.5402 |
Biodegradation | Not ready biodegradable | 0.8665 |
Acute Oral Toxicity | III | 0.8381 |
Carcinogenicity (Three-class) | Non-required | 0.7083 |